Sastasundar Ventures Limited has informed the Exchange about Copy of Newspaper Publication of Audited Financial Results for the quarter and financial year ended 31st March, 2025
HEALTHX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sastasundar Ventures has submitted copies of its audited financial results for the quarter and financial year ended 31 March 2025, as published in Financial Express (English) and Ek Din (Bengali) on 1 June 2025, in line with SEBI Regulation 47. On a consolidated basis, full-year FY25 revenue stood at around Rs. 1,110.95 crore versus Rs. 1,375.71 crore in FY24, a roughly 19% decline. The company swung from a consolidated net profit of Rs. 5.85 crore in FY24 to a consolidated net loss of Rs. 133.54 crore in FY25. Standalone operations continued to report losses, with FY25 standalone net loss at Rs. 71.37 lakh versus Rs. 89.29 lakh in FY24. The results were approved by the Board on 30 May 2025.
For shareholders, this is a routine regulatory disclosure of already-approved results, but the sharp swing from a small consolidated profit last year to a sizeable loss this year signals weak operational performance and may weigh on the stock sentiment. The results were not newly announced in this filing, so expect limited immediate price reaction beyond follow-through from the original results announcement.